CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Gayathri Udyawar
/ Categories: Trending, Markets

Mid-cap, small-cap outperforms

The broad market indices BSE Mid-cap and Small-cap index registered handsome gains. The BSE Mid-cap index gained 0.62 per cent, while small-cap index was up by 1.37 per cent on Monday.

 

Among the BSE Mid-cap index stocks, ICICI Securities Ltd was the top gainer, which was up 8.05 per cent, followed by Mphasis, Adani Power which were up by 7.24 and 6.75 per cent, respectively.

 

On the other hand, the small-cap pack was led by Uttam Sugar, GTPL, Aptech, Trident, which hit their upper circuit limits and were up by 20 per cent each. The rally in the Small-cap index can be attributed to good results and a rally in sugar stocks.

 

Meanwhile, the benchmark indices BSE Sensex closed at 34,865.10, up by 131.52 or 0.38 per cent and Nifty50 closed at 10,512.50, up by 40.00 or 0.38 per cent on Monday. Among BSE Sensex stocks, Infy, ITC, ONGC, TCS and Sun Pharma were the top gainers. While among Nifty50 Dr. Reddy, Cipla, Infy, Hindalco and ITC topped the chart.

Previous Article Benchmark indices bewildered, CPI and WPI moderately higher
Next Article Lupin receives tentative USFDA approval, stock tops Nifty pharma
Print
953 Rate this article:
5.0
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR